These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33397564)

  • 1. Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris.
    Gupta AK; Bruce A; Vincent KD; Abramovits W
    Skinmed; 2020; 18(6):354-357. PubMed ID: 33397564
    [No Abstract]   [Full Text] [Related]  

  • 2. Minocycline foam (Amzeeq) for acne.
    Med Lett Drugs Ther; 2020 May; 62(1597):68-70. PubMed ID: 32555112
    [No Abstract]   [Full Text] [Related]  

  • 3. Minocycline Topical Foam: A New Drug for the Treatment of Acne.
    Onge ES; Mobley WC
    Ann Pharmacother; 2021 Jan; 55(1):105-110. PubMed ID: 32618475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.
    Jones TM; Ellman H; deVries T
    J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
    Paik J
    Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.
    Shemer A; Shiri J; Mashiah J; Farhi R; Gupta AK
    J Am Acad Dermatol; 2016 Jun; 74(6):1251-2. PubMed ID: 27185426
    [No Abstract]   [Full Text] [Related]  

  • 7. Solodyn (Minocycline HCl, USP) extended-release tablets.
    Gupta AK; Gover MD; Abramovits W; Perlmutter A
    Skinmed; 2006; 5(6):291-2. PubMed ID: 17085996
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
    Raoof TJ; Hooper D; Moore A; Zaiac M; Sullivan T; Kircik L; Lain E; Jankicevic J; Stuart I
    J Am Acad Dermatol; 2020 Apr; 82(4):832-837. PubMed ID: 31163231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating FMX-101 as a promising therapeutic for the treatment of acne.
    Valente Duarte de Sousa IC
    Expert Opin Pharmacother; 2020 May; 21(7):741-746. PubMed ID: 32037906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit-risk assessment of acne therapies.
    Seukeran DC; Eady EA; Cunliffe WJ
    Lancet; 1997 Apr; 349(9060):1251-2. PubMed ID: 9130967
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.
    Gold LS; Dhawan S; Weiss J; Draelos ZD; Ellman H; Stuart IA
    J Am Acad Dermatol; 2019 Jan; 80(1):168-177. PubMed ID: 30165171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris.
    Benjamin RW; Calikoglu AS
    Pediatr Dermatol; 2007; 24(3):246-9. PubMed ID: 17542873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minocycline in Acne--an autoimmune disease-like syndrome as a side effect].
    Jagusch W; Gruppe W
    Hautarzt; 1996 Dec; 47(12):936. PubMed ID: 9081943
    [No Abstract]   [Full Text] [Related]  

  • 14. Minocycline-induced hyperpigmentation.
    Jung Kim S; English JC
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):77-8. PubMed ID: 22319793
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline in acne is still an issue.
    Corona R
    Arch Dermatol; 2000 Sep; 136(9):1143-5. PubMed ID: 10987872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute hepatitis and minocycline].
    Real Martínez Y; Medina S
    Rev Esp Enferm Dig; 2003 Oct; 95(10):741-2. PubMed ID: 14588070
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating Acne With Topical Antibiotics: Current Obstacles and the Introduction of Topical Minocycline as a New Treatment Option.
    Bonati LM; Dover JS
    J Drugs Dermatol; 2019 Mar; 18(3):240-244. PubMed ID: 30909327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline-induced pigmentation of the skin and nails.
    Ali FR; Yiu ZZ; Ogden S
    Postgrad Med J; 2015 Nov; 91(1081):662. PubMed ID: 26500011
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
    Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC
    Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.